These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 3525362)

  • 21. Oral hypoglycaemic agents: the first thirty years.
    Nabarro JD
    J R Coll Physicians Lond; 1992 Jan; 26(1):50-5. PubMed ID: 1573584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duration of residual B-cell function in maturity-onset diabetes.
    Cignarelli M; Cospite MR; Stefanelli G; Guastamacchia E; Nardelli G; Giorgino R
    Acta Diabetol Lat; 1984; 21(2):161-6. PubMed ID: 6382892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of C-peptide level measurements in diabetes mellitus.
    Rajasoorya C; Tan YT; Chew LS
    Ann Acad Med Singap; 1990 Jul; 19(4):463-6. PubMed ID: 2221804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Retrospective analysis of secondary failure of oral hypoglycemic drugs in patients with diabetes type II].
    Strojek K; Pietraszek F; Pokrzywnicki W; Grzeszczak W
    Pol Arch Med Wewn; 1994 Feb; 91(2):113-7. PubMed ID: 8008616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Report of the 11th EASD Islet Group meeting. Glasgow, UK, 13-15 September 2001.
    Furman BL; Flatt PR
    Diabetologia; 2002 Jun; 45(6):R26-9. PubMed ID: 12154777
    [No Abstract]   [Full Text] [Related]  

  • 26. [Monogenic diabetes: a useful dimension for diabetology practice].
    Valéro R; Béliard S; Paquis-Fluckinger V; Vialettes B
    Ann Endocrinol (Paris); 2005 Jun; 66(3):279-83. PubMed ID: 15988391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral hypoglycaemic activity of an anhydroformaldehyde aniline-insulin mixture.
    Wales JK; Bradley P; Wolff FW
    Nature; 1966 Jul; 211(5044):88-9. PubMed ID: 5967478
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies in possible oral hypoglycaemic agents. II. Synthesis of hydantoins and hydantoic esters by alternate methods.
    DHAR DN; POPLI SP; DHAR ML
    J Sci Ind Res (C); 1961 May; 20C():145-7. PubMed ID: 13722426
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral antidiabetic drug use in the elderly.
    Bressler R; Johnson DG
    Drugs Aging; 1996 Dec; 9(6):418-37. PubMed ID: 8972242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic B-cell function in relation to diabetic retinopathy in Asian Indian NIDDM patients.
    Snehalatha C; Mohan R; Mohan V; Ramachandran A; Viswanathan M
    Acta Diabetol Lat; 1988; 25(2):95-100. PubMed ID: 3066087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety aspects of oral hypoglycaemic agents.
    Rosskamp R
    Diabetologia; 1996 Dec; 39(12):1668-72. PubMed ID: 9081853
    [No Abstract]   [Full Text] [Related]  

  • 32. Beta cell function in long term NIDDM (type 2) patients and its relation to treatment.
    Snehalatha C; Ramachandran A; Mohan V; Timothy H; Viswanathan M
    Horm Metab Res; 1986 Jun; 18(6):391-4. PubMed ID: 3525362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic beta cell response in insulin treated NIDDM patients limitations of a random C-peptide measurement.
    Snehalatha C; Ramachandran A; Mohan V; Viswanathan M
    Diabete Metab; 1987 Feb; 13(1):27-30. PubMed ID: 3552773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.